Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Functional inspiratory muscle training group: Patients will be given fundamental inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, the training will be used as a home program. In the 5th week, the functional inspiratory muscle training program will be started. Before the program begins, patients will be shown the exercises in the functional inspiratory muscle training program. Patients will be given functional inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, fundamental inspiratory muscle training will be used as a home program. Pressure increases will be made weekly to 10 centimeters of water (cmH2O). Unsupervised training sessions will be followed by charts filled out by patients.

Control group: The control group will not be given any training during the 8-week period. After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.

Study summary

Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. Diaphragmatic activity and lung compliance decrease due to surgery. Peripheral and respiratory muscle functions are impaired in patients with lung cancer, exercise capacity and physical activity level decreased. Patients have postural instability and balance problems. Inspiratory muscle training has increased inspiratory muscle strength in patients with lung cancer. However, there is no study investigating functional inspiratory muscle training in patients with lung cancer.

Eligibility

Primary outcome measure(s)

• Oxygen Consumption — Trough study completion, an average of 2 year
  Maximum exercise capacity will be assessed by symptom-limited cardiopulmonary exercise testing on a treadmill at gradually increasing speed and degree, and oxygen consumption will be measured during the test.
• Muscle oxygenation — Trough study completion, an average of 2 year
  Muscle oxygenation of the quadriceps femoris (during the exercise test) and the diaphragm, scalene muscles, sternocleidomastoid muscle, and rectus abdominis muscle (at rest) will be assessed with a muscle oxygen monitor.
• Balance — Trough study completion, an average of 2 year
  Balance will be evaluated using a balance assessment device.
• Balance (timed up and go test) — Trough study completion, an average of 2 year
  Balance will be evaluated a timed up and go test.
• Physical activity level — Trough study completion, an average of 2 year
  A multi-sensor activity monitor will be used to assess the level of physical activity.

Trial sites (1)

More Gazi University trials in Turkey

Other trials for the same condition